Literature DB >> 29279377

Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia.

Bing Chen1, Lu Jiang1, Meng-Ling Zhong1, Jian-Feng Li1, Ben-Shang Li2, Li-Jun Peng1, Yu-Ting Dai1, Bo-Wen Cui1, Tian-Qi Yan1, Wei-Na Zhang1, Xiang-Qin Weng1, Yin-Yin Xie1, Jing Lu1, Rui-Bao Ren1, Su-Ning Chen3, Jian-Da Hu4, De-Pei Wu3, Zhu Chen5, Jing-Yan Tang6, Jin-Yan Huang5, Jian-Qing Mi5, Sai-Juan Chen5.   

Abstract

T-cell acute lymphoblastic leukemia (T-ALL) is a clonal malignancy of immature T cells. Recently, the next-generation sequencing approach has allowed systematic identification of molecular features in pediatric T-ALL. Here, by performing RNA-sequencing and other genomewide analysis, we investigated the genomic landscape in 61 adult and 69 pediatric T-ALL cases. Thirty-six distinct gene fusion transcripts were identified, with SET-NUP214 being highly related to adult cases. Among 18 previously unknown fusions, ZBTB16-ABL1, TRA-SALL2, and involvement of NKX2-1 were recurrent events. ZBTB16-ABL1 functioned as a leukemogenic driver and responded to the effect of tyrosine kinase inhibitors. Among 48 genes with mutation rates >3%, 6 were newly found in T-ALL. An aberrantly overexpressed short mRNA transcript of the SLC17A9 gene was revealed in most cases with overexpressed TAL1, which predicted a poor prognosis in the adult group. Up-regulation of HOXA, MEF2C, and LYL1 was often present in adult cases, while TAL1 overexpression was detected mainly in the pediatric group. Although most gene fusions were mutually exclusive, they coexisted with gene mutations. These genetic abnormalities were correlated with deregulated gene expression markers in three subgroups. This study may further enrich the current knowledge of T-ALL molecular pathogenesis.

Entities:  

Keywords:  T-ALL; ZBTB16-ABL1; fusion gene; gene mutation; transcriptome

Mesh:

Substances:

Year:  2017        PMID: 29279377      PMCID: PMC5777070          DOI: 10.1073/pnas.1717125115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element.

Authors:  Marc R Mansour; Brian J Abraham; Lars Anders; Alla Berezovskaya; Alejandro Gutierrez; Adam D Durbin; Julia Etchin; Lee Lawton; Stephen E Sallan; Lewis B Silverman; Mignon L Loh; Stephen P Hunger; Takaomi Sanda; Richard A Young; A Thomas Look
Journal:  Science       Date:  2014-11-13       Impact factor: 47.728

2.  Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome.

Authors:  G Q Daley; R A Van Etten; D Baltimore
Journal:  Science       Date:  1990-02-16       Impact factor: 47.728

Review 3.  Genetic Basis of Acute Lymphoblastic Leukemia.

Authors:  Ilaria Iacobucci; Charles G Mullighan
Journal:  J Clin Oncol       Date:  2017-02-13       Impact factor: 44.544

4.  Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia.

Authors:  Priscila P Zenatti; Daniel Ribeiro; Wenqing Li; Linda Zuurbier; Milene C Silva; Maddalena Paganin; Julia Tritapoe; Julie A Hixon; André B Silveira; Bruno A Cardoso; Leonor M Sarmento; Nádia Correia; Maria L Toribio; Jörg Kobarg; Martin Horstmann; Rob Pieters; Silvia R Brandalise; Adolfo A Ferrando; Jules P Meijerink; Scott K Durum; J Andrés Yunes; João T Barata
Journal:  Nat Genet       Date:  2011-09-04       Impact factor: 38.330

5.  Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia.

Authors:  Elaine Coustan-Smith; Charles G Mullighan; Mihaela Onciu; Frederick G Behm; Susana C Raimondi; Deqing Pei; Cheng Cheng; Xiaoping Su; Jeffrey E Rubnitz; Giuseppe Basso; Andrea Biondi; Ching-Hon Pui; James R Downing; Dario Campana
Journal:  Lancet Oncol       Date:  2009-01-13       Impact factor: 41.316

Review 6.  Acute lymphoblastic leukaemia.

Authors:  Ching-Hon Pui; Leslie L Robison; A Thomas Look
Journal:  Lancet       Date:  2008-03-22       Impact factor: 79.321

7.  SIL-TAL1 deletion in T-cell acute lymphoblastic leukemia.

Authors:  J W Janssen; W D Ludwig; W Sterry; C R Bartram
Journal:  Leukemia       Date:  1993-08       Impact factor: 11.528

8.  Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.

Authors:  Adolfo A Ferrando; Donna S Neuberg; Jane Staunton; Mignon L Loh; Christine Huard; Susana C Raimondi; Fred G Behm; Ching Hon Pui; James R Downing; D Gary Gilliland; Eric S Lander; Todd R Golub; A Thomas Look
Journal:  Cancer Cell       Date:  2002-02       Impact factor: 31.743

9.  Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors.

Authors:  Stephen L Nutt; Donald Metcalf; Angela D'Amico; Matthew Polli; Li Wu
Journal:  J Exp Med       Date:  2005-01-17       Impact factor: 14.307

10.  Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia.

Authors:  Henrik Lilljebjörn; Rasmus Henningsson; Axel Hyrenius-Wittsten; Linda Olsson; Christina Orsmark-Pietras; Sofia von Palffy; Maria Askmyr; Marianne Rissler; Martin Schrappe; Gunnar Cario; Anders Castor; Cornelis J H Pronk; Mikael Behrendtz; Felix Mitelman; Bertil Johansson; Kajsa Paulsson; Anna K Andersson; Magnus Fontes; Thoas Fioretos
Journal:  Nat Commun       Date:  2016-06-06       Impact factor: 14.919

View more
  45 in total

Review 1.  Updates in the Pathology of Precursor Lymphoid Neoplasms in the Revised Fourth Edition of the WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues.

Authors:  Christopher Wenzinger; Eli Williams; Alejandro A Gru
Journal:  Curr Hematol Malig Rep       Date:  2018-08       Impact factor: 3.952

2.  Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases.

Authors:  Jian-Feng Li; Yu-Ting Dai; Henrik Lilljebjörn; Shu-Hong Shen; Bo-Wen Cui; Ling Bai; Yuan-Fang Liu; Mao-Xiang Qian; Yasuo Kubota; Hitoshi Kiyoi; Itaru Matsumura; Yasushi Miyazaki; Linda Olsson; Ah Moy Tan; Hany Ariffin; Jing Chen; Junko Takita; Takahiko Yasuda; Hiroyuki Mano; Bertil Johansson; Jun J Yang; Allen Eng-Juh Yeoh; Fumihiko Hayakawa; Zhu Chen; Ching-Hon Pui; Thoas Fioretos; Sai-Juan Chen; Jin-Yan Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-28       Impact factor: 11.205

Review 3.  Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia.

Authors:  Jianfeng Li; Yuting Dai; Liang Wu; Ming Zhang; Wen Ouyang; Jinyan Huang; Saijuan Chen
Journal:  Front Med       Date:  2021-01-05       Impact factor: 4.592

Review 4.  IKZF1 deletions in pediatric acute lymphoblastic leukemia: still a poor prognostic marker?

Authors:  Martin Stanulla; Hélène Cavé; Anthony V Moorman
Journal:  Blood       Date:  2020-01-23       Impact factor: 22.113

5.  Multidimensional study of the heterogeneity of leukemia cells in t(8;21) acute myelogenous leukemia identifies the subtype with poor outcome.

Authors:  Lu Jiang; Xue-Ping Li; Yu-Ting Dai; Bing Chen; Xiang-Qin Weng; Shu-Min Xiong; Min Zhang; Jin-Yan Huang; Zhu Chen; Sai-Juan Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-03       Impact factor: 11.205

Review 6.  Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignancies.

Authors:  Nicole L Michmerhuizen; Jeffery M Klco; Charles G Mullighan
Journal:  Blood       Date:  2020-11-12       Impact factor: 22.113

7.  An allosteric PGAM1 inhibitor effectively suppresses pancreatic ductal adenocarcinoma.

Authors:  Chen-Lei Wen; Ke Huang; Lu-Lu Jiang; Xiong-Xiong Lu; Yu-Ting Dai; Min-Min Shi; Xiao-Mei Tang; Qing-Bing Wang; Xiao-Dan Zhang; Peng-Hui Wang; Hui-Ti Li; Xiao-Xue Ruan; Li-Wen Wang; Xin-Jing Wang; Qian Wang; Wei Lu; Xiao-Qiang Xiang; Xun Sun; Yan-Hui Xu; Lu-Hua Lai; Qian Zhan; Hong-Wei Li; Cheng-Hong Peng; Jing Chen; Jin-Yan Huang; De-Yong Ye; Sai-Juan Chen; Zhu Chen; Min Li; Yuan Fang; Bai-Yong Shen; Lu Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-29       Impact factor: 11.205

8.  DLX5 promotes osteosarcoma progression via activation of the NOTCH signaling pathway.

Authors:  Xiaojing Zhang; Huiqin Bian; Wei Wei; Qian Wang; Jinnan Chen; Ruoxuan Hei; Chen Chen; Xuan Wu; Haochun Yuan; Junxia Gu; Yaojuan Lu; Cheguo Cai; Qiping Zheng
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

Review 9.  Interstitial Deletions Generating Fusion Genes.

Authors:  Ioannis Panagopoulos; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2021 May-Jun       Impact factor: 4.069

10.  Large-Scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood Cancers.

Authors:  Julie E Feusier; Sasi Arunachalam; Tsewang Tashi; Monika J Baker; Chad VanSant-Webb; Amber Ferdig; Bryan E Welm; Juan L Rodriguez-Flores; Christopher Ours; Lynn B Jorde; Josef T Prchal; Clinton C Mason
Journal:  Blood Cancer Discov       Date:  2021-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.